---
title: "Tarsus Pharmaceuticals (TARS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TARS.US/norm.md"
symbol: "TARS.US"
name: "Tarsus Pharmaceuticals"
parent: "https://longbridge.com/en/quote/TARS.US.md"
datetime: "2026-03-05T08:08:50.542Z"
locales:
  - [en](https://longbridge.com/en/quote/TARS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TARS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TARS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/TARS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TARS.US/norm.md)


# Tarsus Pharmaceuticals (TARS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1957 | -0.2954 | -0.4802 | -0.6384 | -0.5994 |
| ROE | -9.87% | -15.08% | -24.10% | -35.44% | -40.02% |
| Revenue | 151.67M | 118.70M | 102.66M | 78.33M | 66.41M |
| Net income | -8.37M | -12.59M | -20.34M | -25.12M | -23.11M |
| Operating income | -7.98M | -14.53M | -22.18M | -26.28M | -24.42M |
| Gross margin | 80.90% | 79.28% | 78.73% | 74.95% | 67.17% |
| Net margin | -5.52% | -10.60% | -19.81% | -32.07% | -34.80% |
| Profit quality | -41.26% | -79.58% | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 562.16M | 534.56M | 494.99M | 500.75M | 376.99M |
| Leverage | 1.64 | 1.60 | 1.49 | 1.46 | 1.68 |
| BVPS | 8.07 | 7.89 | 7.88 | 8.15 | 5.85 |
| Turnover | 0.9612 | 0.8039 | 0.6779 | 0.5498 | 0.5695 |
| Cash & STI | 417.27M | 401.84M | 381.14M | 407.92M | 291.38M |
| Inv & Rec | 4.37M | 3.84M | 3.87M | 2.71M | 2.62M |
| LT assets | 21.75M | 15.98M | 3.41M | 3.18M | 2.87M |
| Net debt | -334.23M | -319.33M | -308.70M | -335.55M | -218.92M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 19.33M | 18.26M | -29.39M | -20.65M | -22.18M |
| Investing CF | 49.27M | -4.74M | -51.70M | -34.94M | -59.57M |
| Financing CF | 2.31M | 2.56M | 1.95M | 136.56M | 2.93M |
| Free CF | 16.49M | 22.17M | -22.60M | -11.23M | -22.90M |
| OCF coverage | 304.03% | 955.86% | -2935.76% | -3500.17% | -30808.33% |
| Repaid & issued | - | - | - | - | 0.0000 |
| CapEx | -6.36M | -1.91M | -1.00M | -590000.00 | -72000.00 |